Poupaert J H, Cavalier R, Claesen M H, Dumont P A
J Med Chem. 1975 Dec;18(12):1268-71. doi: 10.1021/jm00246a024.
Chemical conversions, optical comparisons, and chiroptical measurements (CD) were employed to determine the absolute configuration of the enantiomers of 5-(4'-hydroxyphenyl)-5-phenylhydantoin (HPPH) (1b and 1c). Studies on a key intermediate, (-)-2-cyclohexyl-2-phenylglycine (5b), led to the reexamination of the well-known rule of Clough-Lutz-Jirgensons. Optical comparisons by means of derivatization into hydantoins and 3-phenyl-2-thiohydantoins (application of Freudenberg's rule of shift) gave conclusions which were consistent with chiroptical measurements on the above compounds. Thus, (-)-HPPH (1c), the major metabolite of 5,5-diphenylhydantoin in man, has the S configuration. This assignment was confirmed by X-ray single-crystal structure analysis of (+)-HPPH 10-(+)-camphorsulfonate (18b).
采用化学转化、光学比较和圆二色光谱测量(CD)来确定5-(4'-羟基苯基)-5-苯基乙内酰脲(HPPH)(1b和1c)对映体的绝对构型。对关键中间体(-)-2-环己基-2-苯基甘氨酸(5b)的研究促使人们重新审视了著名的克拉夫-卢茨-吉尔根森规则。通过衍生化为乙内酰脲和3-苯基-2-硫代乙内酰脲进行光学比较(应用弗罗伊登贝格位移规则)得出的结论与对上述化合物的圆二色光谱测量结果一致。因此,(-)-HPPH(1c),即5,5-二苯基乙内酰脲在人体内的主要代谢产物,具有S构型。通过(+)-HPPH 10-(+)-樟脑磺酸盐(18b)的X射线单晶结构分析证实了这一构型归属。